Which country developed and produced Venetoclax?

Venetoclax/Venetoclax (Venetoclax) is a targeted therapy drug developed by the American company AbbVie (AbbVie) and Genentech (Genentech). AbbVie is a pharmaceutical company headquartered in the United States, and Genentech is a biotechnology company in California, currently a subsidiary of Roche (Roche).

Venetoclax/Venetoclax was originally developed by the Walter and Eliza Hall Institute of Medical Research in Melbourne, Victoria, Australia (Walter and Eliza It was discovered by scientists at the Hall Institute of Medicine) and further developed in collaboration with AbbVie and Genentech. The research and development of this drug involved in-depth molecular biology and drug development work, aiming to achieve targeted therapy of cancer cells by interfering with the activity of BCL-2 protein in B cell lymphoma and chronic lymphocytic leukemia.

Venetoclax/Venetoclax obtained emergency use authorization (EUA) in the United States in 2016 and was subsequently gradually approved in other countries and regions, becoming one of the first-line drugs for the treatment of specific types of hematological malignancies.

Venetoclax/VenetoclaxThe development and launch of the drug provides a more personalized and effective treatment method for patients with hematological malignancies, and also demonstrates the positive results of cooperation between the international scientific community and the pharmaceutical industry. This successful experience not only provides a model for similar collaborations in the future, but also brings more hope and opportunities to patients, especially those facing refractory or relapsed hematological malignancies.

Venetoclax/Venetoclax has been launched in China and has been included in medical insurance, and patients can purchase it domestically. Specifications: 100mg*14tablets and the price is around 5,000yuan. Please consult the local hospital pharmacy for specific prices. There are original drugs and generic drugs abroad. The Turkish version of Venetoclax/Venetoclaxoriginal drug on the market overseas, specification: 100mg*112 tablets, costs about 10,000 per box. Foreign generic drugs are relatively cheaper. For example, the generic drugs sold in Laos and Bangladesh are priced at about more than 4,000 yuan for 100mg*120 tablets. The ingredients of original drugs and generic drugs are basically the same.